Search company, investor...

Total Raised

$203.14M

Investors Count

13

Deal Terms

2

Funding, Valuation & Revenue

15 Fundings

AcuFocus has raised $203.14M over 15 rounds.

AcuFocus's latest funding round was a Acquired for on January 17, 2023.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

1/17/2023

Acquired

$99M

0

FY undefined

9

8/20/2018

Series H

$23.97M

$99M

0

FY undefined

1

9/9/2016

Series G

$66M

$99M

0

FY undefined

15

8/24/2016

Debt - III

$99M

$99M

0

FY undefined

10

7/8/2016

Debt - II

$99M

$99M

0

FY undefined

10

Date

1/17/2023

8/20/2018

9/9/2016

8/24/2016

7/8/2016

Round

Acquired

Series H

Series G

Debt - III

Debt - II

Amount

$23.97M

$66M

$99M

$99M

Investors

Valuation

$99M

$99M

$99M

$99M

$99M

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

9

1

15

10

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

AcuFocus Deal Terms

2 Deal Terms

AcuFocus's deal structure is available for 2 funding rounds, including their Series E from November 29, 2011.

Round

Series E

Series B

Funding Date

$99M

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

$99M

Shares Authorized

Issuance Price

$99M

Dividend Rate

$99M

Liquidation Preferences

$99M

Liquidation Price

Participation

Conversion Price

Anti Dilution

$99M

General Voting

$99M

$99M

Board Voting

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series E

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series B

$99M

$99M

$99M

$99M

AcuFocus Investors

13 Investors

AcuFocus has 13 investors. Bausch & Lomb UK invested in AcuFocus's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

12/17/2008

1/17/2023

4
Other Investors, Series D (2008), Series E (2011), Acquired (2023)

Corporation

Canada

11/18/2002

8/20/2018

6
Series B, Series C (2005), Series D (2008), Series E (2011), Series F (2014), Series H (2018)

Venture Capital

California

9/9/2016

8/20/2018

2
Series G, Series H (2018)

Arjun Arora

Private Equity

New York

00/00/0000

00/00/0000

SightLine Partners

Subscribe to see more

Venture Capital

Minnesota

00/00/0000

00/00/0000

SV Health Investors

Subscribe to see more

Venture Capital

United Kingdom

First funding

12/17/2008

11/18/2002

9/9/2016

00/00/0000

00/00/0000

Last Funding

1/17/2023

8/20/2018

8/20/2018

00/00/0000

00/00/0000

Investor

SightLine Partners

SV Health Investors

Rounds

4
Other Investors, Series D (2008), Series E (2011), Acquired (2023)
6
Series B, Series C (2005), Series D (2008), Series E (2011), Series F (2014), Series H (2018)
2
Series G, Series H (2018)

Subscribe to see more

Subscribe to see more

Board Seats

Arjun Arora

Type

Corporation

Venture Capital

Private Equity

Venture Capital

Venture Capital

Location

Canada

California

New York

Minnesota

United Kingdom

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare AcuFocus to Competitors

Neoss Logo
Neoss

Neoss develops dental implant technology. It helps in reducing patient treatment time, optimizing inventory control, and superior outcomes for patients. It was founded in 2000 and is based in Zurich, Switzerland.

Spineology Logo
Spineology

Spineology provides anatomy-conserving spinal technologies for surgeons and their patients. Its surgical techniques conserve spinal bone, ligament, and muscle tissue, committed to increasing procedural efficiency, reducing surgical morbidity, and accelerating patient recovery. The company was founded in 1996 and is based in Saint Paul, Minnesota.

E
EyeTechCare

EyeTechCare is a company focused on the healthcare sector, specifically in the field of glaucoma treatment. The company offers non-invasive solutions for glaucoma patients, utilizing focused ultrasound technology to manage the condition. EyeTechCare primarily serves the healthcare industry, particularly those dealing with eye health and glaucoma treatment. It was founded in 2008 and is based in Rillieux-la-Pape, France.

N
NovaLign Orthopaedics

NovaLign Orthopaedics, formerly known as OsteoLign, is developing a minimally invasive solution for long bone fractures.

S
Simpirica Spine

Simpirica is developing a dynamic stabilization system designed to stabilize the spine in flexion and help patients return to more healthy, active lifestyles. The company's lead product, the LimiFlex Spinal Stabilization System, is typically used in conjunction with a surgical decompression for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis.

D
Dental Implants

Dental Implant Technologies (DIT) is a San Antonio based dental technology company providing an end to end suite of integrated implant based restorative services and products for dental patients requiring the replacement of most or all of their teeth. In the United States alone this market includes 30M individuals or a served addressable market of $96B including $26B for DIT's products and services. It is based in Scottsdale, Arizona.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.